$7.37
-0.38-4.9%
Ult. Agg.: Nov 6, 4:00 PM
The average analyst price target for Akari Therapeutics is $32.33, 304.1% above the current price. Of 3 analysts, 3 rate it Buy. Targets range from $27 to $40. The latest change came on Jul 20, 2026, when Maxim Group upgraded Akari Therapeutics from Hold to Buy with a $30 price target.
Price Target Range — 4 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months